NEU neuren pharmaceuticals limited

Ann: Update - Notification of buy-back - NEU, page-16

  1. 2,737 Posts.
    lightbulb Created with Sketch. 1050
    It controls your downside risk until such time as favourable conditions exist.

    Let's say a Fund wants to take a position. They like the long term potential of NEU but don't see any reason for a significant re-rate in the near term (or are worried about sector or poor market conditions being a drag on the stock). Looking at NEU price leading up to and post announcing it's Ph3 start for trof provides a good reference point for this. But the fund also doesn't want to try and build a position when everyone is clamouring for the stock in 2 years time either. So they build a position and hedge their downside risk because lord knows you don't want to be holding too many positions in your fund that are down 50%. Won't have much FUM left if that keeps happening. Fund managers try and smooth out volatility and risk and 'hedging' of long positions is one way to do that.

    I think we can all agree that the majority of returns to be made in NEU in the next 2 years will be post Ph 3 results, presuming they are good. I can't see us re-rating above $30 on Daybue results results alone, not in the next 2 years anyway, unless Acadia smash it out of the park.
    Last edited by nashezz: 09/05/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.96
Change
-0.140(1.07%)
Mkt cap ! $1.612B
Open High Low Value Volume
$13.20 $13.36 $12.82 $4.627M 354.8K

Buyers (Bids)

No. Vol. Price($)
1 7585 $12.96
 

Sellers (Offers)

Price($) Vol. No.
$13.03 3344 2
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.